Scott Gottlieb ’94, a physician, public health and policy advisor and advocate, received an honorary doctorate of science during Wesleyan’s 189th Commencement on Wednesday, May 26. Gottlieb, who earned a BA in economics from Wesleyan, was the commissioner of the Food and Drug Administration (FDA) from 2017 to 2019. He is currently a special partner with the venture capital firm New Enterprise Associates, and a resident fellow at public policy think tank the American Enterprise Institute (AEI).
In his speech, Gottlieb drew distinctions between his time at Wesleyan 25 years ago and the experiences of the Class of 2021. Yet he highlighted characteristics shared by all Wesleyan students: the “seriousness” in academic studies, the belief that actions can “transcend the University boundaries to influence the country,” and the feeling of “obligation” to make a difference in individual communities.
“I hope you take that spirit into this uncertain period we’re in, at this very decisive juncture in history, when the country may be more ready than it’s been in many years to hear your voices, and to set about making lasting changes,” he said.
He made the following remarks (as prepared) during Wesleyan’s 189th Commencement Ceremony:
It’s an honor to be here with you today. Twenty-five years ago, I sat here at my own graduation. it was very different. We didn’t have masks. We weren’t social distancing. Senior year was a lot different.